Medical device maker Kensey Nash Corp. (KNSY) produces biomaterial products that seal arterial punctures, dress wounds and treat burns. The Eston, Pa.-based company is scheduled to discuss its fiscal fourth-quarter and full-year financial results Monday, August 23, in a conference call beginning at 9:00 AM (ET) hosted by CEO Joe Kaufmann. You can catch a live webcast at the Kensey Nash's website.
During the three months that ended in June, Kensey Nash announced a strategic partnership with a sports medicine products company, and it also announced a share buyback program. Analysts surveyed by Thomson Reuters expect Kensey Nash to report earnings of 52 cents per share, up from 41 cents per share in the year-ago period. Its revenue is expected to have risen 4.1% from a year ago to $21.3 million.
Savings Experiment: Snow Removal
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger.gif)


